Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma.
Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
E
E
Spanoudakis
Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
M
M
Papoutselis
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece.
E
E
Terpos
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece.
M A
MA
Dimopoulos
Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
C
C
Tsatalas
Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
D
D
Margaritis
Centre for Haematology, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK.
A
A
Rahemtulla
Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
I
I
Kotsianidis
Centre for Haematology, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK.
A
0000-0002-9566-9780
A
Karadimitris
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001853:Bone Marrow / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D001854:Bone Marrow Cells / Q000378:metabolism / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000235:genetics* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D055611:Natural Killer T-Cells / Q000378:metabolism* / Q000473:pathology; D053245:RANK Ligand / Q000235:genetics*; D015854:Up-Regulation / Q000235:genetics
D053245:RANK Ligand; C505688:TNFSF11 protein, human